{"nct_id":"NCT03740165","title":"Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2018-12-18","start_date_type":"ACTUAL","primary_completion_date":"2024-08-26","primary_completion_date_type":"ACTUAL","completion_date":"2026-05-29","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}